Back
Ovid Therapeutics, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
30
OVID
Ovid Therapeutics, Inc.
Last Price:
$1.63
Seasonality Move:
-8.1%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiOvid Therapeutics, Inc. Stock Forecast
-
Is Ovid Therapeutics, Inc. Stock Undervalued?The current Ovid Therapeutics, Inc. [OVID] share price is $1.62. The Score for OVID is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
OVID is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Ovid Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Ovid Therapeutics, Inc. Stock Rating
Data Unavailable
Ovid Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ovidrx.com
52-Week Data
52-Week High:
2.01
52-Week Low:
0.24
Prediction Charts
Market Cap:
115.4M
Price in USD:
1.62
Volume:
1.5M
Beta:
1.01
Technical Analysis
SMA50:
1.50
SMA100:
1.21
SMA200:
0.79
52-Wk Change:
52.83%
Stock Predictions
-
Is Ovid Therapeutics, Inc. stock public?Yes, Ovid Therapeutics, Inc. is a publicly traded company.
-
What is the Ovid Therapeutics, Inc. stock quote today?The Ovid Therapeutics, Inc. stock price is 1.62 USD today.
-
How to buy Ovid Therapeutics, Inc. stock online?You can buy Ovid Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.19 | 1.31 | 1.33 | 1.18 |
| Nov-17 | 1.33 | 1.30 | 1.38 | 1.26 |
| Nov-18 | 1.28 | 1.32 | 1.33 | 1.24 |
| Nov-19 | 1.35 | 1.28 | 1.35 | 1.25 |
| Nov-20 | 1.28 | 1.22 | 1.36 | 1.21 |
| Nov-21 | 1.24 | 1.40 | 1.41 | 1.23 |
| Nov-24 | 1.44 | 1.49 | 1.56 | 1.42 |
| Nov-25 | 1.51 | 1.50 | 1.53 | 1.44 |
| Nov-26 | 1.52 | 1.63 | 1.66 | 1.52 |
| Nov-28 | 1.67 | 1.78 | 1.81 | 1.58 |
| Dec-1 | 1.74 | 1.80 | 1.82 | 1.67 |
| Dec-2 | 1.78 | 1.56 | 1.79 | 1.56 |
| Dec-3 | 1.46 | 1.58 | 1.60 | 1.45 |
| Dec-4 | 1.55 | 1.62 | 1.67 | 1.55 |
Ovid Therapeutics, Inc. Earnings
Data Unavailable
Ovid Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.09 per share.
* Ovid Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.